Gu
Non verificato

Guardant Health, Inc.

Di cosa scriviamo

BiotecnologiaIndustriaOncologiaSaluteSanità
20/10/2026
Tecnica
Associazioni/Professionisti
Biotecnologia
Farmaceutica
Salute
Information Technology
Oncologia
Eventi
Industria
Guardant Health Highlights Broad Liquid Biopsy Research Portfolio at ESMO Congress 2026
1.00
15/10/2026
Scienza
Biotecnologia
Farmaceutica
Oncologia
Salute
Medicina - Varie
Eventi
Guardant Health Shield Blood Test Demonstrates Leading Screening Adherence and CRC Deaths Averted Compared to Stool-Based Tests
1.00
08/10/2026
Industria
Scienza
Sanità
Associazioni/Professionisti
Farmaceutica
Oncologia
Vetrine/Shopping
Biotecnologia
Salute
Guardant Health Announces Approval in Europe of Guardant360® CDx as Companion Diagnostic for AstraZeneca’s ETCAMAH™ (camizestrant) in Advanced ER-positive Breast Cancer
1.00
08/10/2026
Web e Social Network
Telefonia e Varie
Mercato azionario
Oncologia
Salute
Sanità
Biotecnologia
Guardant Health to Report Third Quarter 2026 Financial Results on November 5, 2026
1.00
14/09/2026
Oncologia
Attrezzature medico-sanitarie
Salute
Biotecnologia
Industria
Guardant Health’s Shield Blood Test Covered by EviCore by Evernorth for Colorectal Cancer Screening
1.00
08/09/2026
Eventi
Oncologia
Information Technology
Salute
Tecnica
Biotecnologia
Business Insider Names Guardant Health One of America's Most Innovative Businesses
1.00

Recapiti

Social Media

Seguaci
0
Compatibilità
0